Influence of body mass index and gender on growth hormone (GH) responses to GH-releasing hormone plus arginine and insulin tolerance tests.
The aim of this study is to assess whether gender and body mass index (BMI) should be considered in developing thresholds to define GH deficiency, using GH responses to GHRH + arginine (ARG) stimulation and insulin tolerance test (ITT). Thirty-nine healthy subjects (19 males, 20 females; ages 21-50 yr) underwent GHRH + ARG, and another 27 subjects (19 males, 8 females; ages 20-49 yr) underwent ITT. Peak GH response was significantly higher (P = 0.005) after GHRH + ARG than with ITT, and this difference could not be explained by age, gender, or BMI. Peak GH response was negatively correlated with BMI in both tests (GHRH + ARG, r = -0.76; and ITT, r = -0.65). Peak GH response to GHRH + ARG was higher in females than males (P = 0.004; ratio = 2.4), but it was attenuated after eliminating the influence of BMI (P = 0.13; ratio = 1.6). No significant gender differences were found in peak GH responses to ITT, which could be due to the smaller number of female subjects studied. GH response to GHRH + ARG and ITT stimulation is sensitive to BMI differences and less so to gender differences. A higher BMI is associated with a depressed GH response to both stimulation tests. BMI should therefore be considered as a factor when defining the diagnostic cut-off points in the assessment of GH deficiency, whereas whether gender should be likewise used is inconclusive from this study.
Qu
Xiao-Dan
XD
General Clinical Research Center, Harbor-University of California Los Angeles (UCLA) Medical Center, 1000 West Carson Street, Torrance, California 90509, USA.
Gaw Gonzalo
Irene T
IT
Al Sayed
Mohammed Y
MY
Cohan
Pejman
P
Christenson
Peter D
PD
Swerdloff
Ronald S
RS
Kelly
Daniel F
DF
Wang
Christina
C
D000328:Adult; D001120:Arginine; D015992:Body Mass Index; D003940:Diagnostic Techniques, Endocrine; D005260:Female; D019382:Human Growth Hormone / Q000097:blood / Q000172:deficiency*; D006801:Humans; D007328:Insulin / Q000378:metabolism; D007333:Insulin Resistance; D008297:Male; D008659:Metabolic Diseases / Q000175:diagnosis*; D008875:Middle Aged; D009842:Oligopeptides; D012727:Sex Characteristics
D007328:Insulin; D009842:Oligopeptides; D019382:Human Growth Hormone; C041048:growth hormone releasing hexapeptide; D001120:Arginine